Clinical trial
To Demonstrate Equivalence in Analgesic Efficacy & Bowel Function Between OXN PR Higher Dose & Lower Dose Tablet Strengths in Subjects With Non-cancer or Cancer Pain
NCT02321397
Study timeline
Study start (unknown)2014-11-01Date precision: month
Registry last updated2016-11-04
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Malignant Painunresolved
Non-malignant Painunresolved
Interventions
OxycodoneDRUG · verified · RxNorm: oxycodone
NaloxoneDRUG · verified · RxNorm: naloxone
Sponsors & collaborators
Mundipharma Research GmbH & Co KGlead sponsor
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT02321397 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.